A hybrid model that combines reps with digital solutions is a win-win for pharmaceutical companies and GPs. With face-to-face rep engagement returning to pre-COVID levels, pharmaceutical companies have an opportunity to use digital lessons learned during the pandemic to significantly increase the reach and frequency of their GP interactions without increasing their budget. The solution
Read moreDeveloping new communication strategies for the digital native doctor
About one in three Australian GPs is a digital native,1 which has fundamental implications for go-to-market strategies and a critical impact on how pharmaceutical companies promote the quality use of their medicines. Digital natives were born after 1980 and raised in an environment in which they were surrounded by technology (Palfrey and Gasser, 2013, Prensky, 2001).
Read moreWhy engaging with GPs outside of working hours is crucial for pharma
Australian prescribers have tasted digital convenience and are unlikely to return to their pre-pandemic levels of face-to-face engagement with pharmaceutical representatives. That’s according to an in-depth report published by AusDoc in 2021 and a follow-up pulse survey among Australian Doctor readers conducted in January 2022[i]. The report titled How a GP initiated engagement model could
Read moreADG & RxTro Partner to support doctors with better access to the information they need
With over 82% of GPs[1] and 90% of pharma sales reps, adg Rep Connect will soon become the largest and most powerful communications platform for doctors and pharmaceutical sales representatives wishing to communicate with each other. To continue to support doctors with getting access to the information they need, we are making some new changes
Read moreHow life sciences organisations can help medical students shift from science to clinical practice
Being a member of the academic elite doesn’t necessarily make a good doctor, an AusDoc survey has revealed. From an experienced doctor’s perspective, high-achieving academics can face problems in practice. “Almost only the academic elite enter the system. This doesn’t necessarily make the best doctors…they are not used to failure and uncertainty and the hospital,
Read moreAn expert’s roadmap to post-COVID and what it means for Pharma
COVID-19 changed GP engagement permanently. A leading modelling expert explains why digital GTM channels are now essential for pharma companies wanting to reach Australian doctors.
Read more5 ways Pharma can help registrars to succeed
GP registrars carry enormous responsibility with limited experience. AusDoc research reveals 5 practical ways pharma can support registrar confidence and build early HCP relationships.
Read more6 key messages you should prioritise when talking to GPs about your product
AusDoc research reveals what Australian GPs actually want from pharma — 6 priority messages that cut through information overload and drive meaningful HCP engagement.
Read more5 key insights to better understand and engage with medical students
Survey uncovers what medical students need and how best to connect with them Helping medical students to succeed in their studies is a key factor in getting their attention, a recent ADG survey* has found. The survey, conducted in February 2021, asked students in their final two years of study about the tensions they face and what they need
Read moreHow has COVID-19 changed GP and pharmaceutical field staff engagement?
With the sudden and dramatic impact of COVID-19, a survey of GPs and their contact with pharmaceutical field staff during the pandemic reveals a massive drop in face-to-face engagement. The joint Australian Doctor Group and Medicines Australia poll was sent out in mid-May and attracted almost 400 responders. It shows prior to the pandemic half
Read more